Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.
Various endocrine neoplasms, including a number of carcinoid and pancreatic islet cell tumours, express somatostatin receptors. These tumours may be difficult to localize using conventional techniques. Radiolabelled somatostatin analogues 123I-Tyr-3-octreotide and 111In-pentatreotide have been used...
Main Authors: | King, C, Reznek, R, Bomanji, J, Ur, E, Britton, K, Grossman, AB, Besser, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1993
|
Similar Items
-
Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
by: Ur, E, et al.
Published: (1993) -
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
by: Kaltsas, G, et al.
Published: (2005) -
The role of somatostatin analogues in the treatment of neuroendocrine tumours.
by: Grozinsky-Glasberg, S, et al.
Published: (2008) -
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
by: Grozinsky-Glasberg, S, et al.
Published: (2008) -
Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487
by: Carroll, P, et al.
Published: (2003)